Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 4Genitourinary 4Gastrointestinal 4Dermatologic 3Breast 3Thoracic 1Classical hematology 1

Conditions

Breast Neoplasms 3Lymphatic Metastasis 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Optical Imaging × Breast × Clear all
NCT07146295 2026-01-12

INFINITE

St. Antonius Hospital

Phase NA Recruiting
1,760 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT00873366 2018-01-23

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Mayo Clinic

Terminated
92 enrolled 20 charts
Breast

Breast Neoplasms

NCT00783757 2017-07-27

TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer

Massachusetts General Hospital

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡